争议事件

品牌回应

• 调查 — Boston Scientific

  Boston Scientific said it is working with cybersecurity experts to assess and contain the threat and to restore affected functions and systems access, but that it doesn't yet have a timeline for a full restoration.

来源摘录

• Boston Scientific on Wednesday said the hack, which is affecting some of its information-technology systems, has caused global disruptions and limitations of access to certain information systems and business applications that support aspects of its operations, including its ability to process and ship customer orders.

• Boston Scientific said it is working with cybersecurity experts to assess and contain the threat and to restore affected functions and systems access, but that it doesn't yet have a timeline for a full restoration.

• Boston Scientific has been hit with a cyberattack that is hampering the medical-technology company's ability to fill orders.

品牌回应

• 召回 — Boston Scientific

  Boston Scientific sent the initial letter to affected customers on July 9, 2026

来源摘录

• The FDA had classified a recall of certain ENROUTE Transcarotid Neuroprotection System and ENROUTE NPS Plus devices as the most serious type of recall — Class I — following reports of arterial sheath tip separation during use.

• Boston Scientific sent the initial letter to affected customers on July 9, 2026

品牌回应

• 否认 — Nevro

  We disagree with the finding by the jury and plan to appeal

来源摘录

• We disagree with the finding by the jury and plan to appeal

• today announced that a Delaware jury found that Nevro infringed two Boston Scientific patents (7,891,085 and 8,019,439) directed to ways of manufacturing spinal cord stimulation (SCS) leads, which Nevro obtains from a third-party supplier. Two other Boston Scientific lead patents (8,646,172 and 8,650,747) were not infringed. The jury awarded Boston Scientific $20 million.